Lindsay McNair, MD, MPH, MSBioethics is the Chief Medical Officer for the WIRB-Copernicus Group. Dr. McNair has extensive experience in the pharmaceutical industry working in clinical research and drug development. Prior to joining WCG, she was a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and study designs for new drug studies, and medical oversight of all phases of clinical trials. Dr. McNair is adjunct faculty at Boston University and teaches graduate-level courses on the scientific design of clinical research studies, research ethics and the responsible conduct of research, and the development of clinical study protocols. She now provides consultation to institutions and pharma/biotech companies on a wide range of issues related to protocol design, regulatory compliance, human subject protection, and ethical policy development (subject compensation, informed consent).
Dr. McNair graduated from the University of Connecticut School of Medicine and trained in general surgery at Boston University Medical Center. She completed her Masters in Public Health at Boston University concentrating in Biostatistics/Epidemiology, and her Masters of Science in Bioethics at Union Graduate College concentrating in research ethics. She was a member of the Institutional Review Board at Boston University Medical Center, and founded and chaired the Human Subject Protection Committee at Vertex Pharmaceuticals. Dr. McNair serves on committees including Bioethics Internationals World Council on Ethical Standards, and contributes to the Multi-Regional Clinical Trials Center at Harvard (including the committee to define essential ethics elements for clinical protocols), and is an associate editor of the Journal of Empirical Research on Human Research Ethics. She was a site visitor for the Association of the Accreditation of Human Research Protection Programs (AAHRPP).